These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

45 related items for PubMed ID: 21352882

  • 1. Time-resolved quantitative analysis of CCK1 receptor-induced intracellular calcium increase.
    Staljanssens D, De Vos WH, Willems P, Van Camp J, Smagghe G.
    Peptides; 2012 Mar; 34(1):219-25. PubMed ID: 21352882
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Protein kinase C-mediated inhibition of transmembrane signalling through CCK(A) and CCK(B) receptors.
    Smeets RL, Fouraux MA, van Emst-de Vries SE, De Pont JJ, Willems PH.
    Br J Pharmacol; 1998 Mar; 123(6):1189-97. PubMed ID: 9559904
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Concerted action of cytosolic Ca2+ and protein kinase C in receptor-mediated phospholipase D activation in Chinese hamster ovary cells expressing the cholecystokinin-A receptor.
    Bosch RR, Smeets RL, Sleutels F, Patel AM, Emst-de Vries SE, Joep J, de Pont HH, Willems PH.
    Biochem J; 1999 Jan 15; 337 ( Pt 2)(Pt 2):263-8. PubMed ID: 9882623
    [Abstract] [Full Text] [Related]

  • 11. Regulation of lateral mobility and cellular trafficking of the CCK receptor by a partial agonist.
    Roettger BF, Pinon DI, Burghardt TP, Miller LJ.
    Am J Physiol; 1999 Mar 15; 276(3):C539-47. PubMed ID: 10069980
    [Abstract] [Full Text] [Related]

  • 12. Photoaffinity labeling of rat pancreatic cholecystokinin type A receptor antagonist binding sites demonstrates the presence of a truncated cholecystokinin type A receptor.
    Poirot SS, Escrieut C, Dufresne M, Martinez J, Bouisson M, Vaysse N, Fourmy D.
    Mol Pharmacol; 1994 Apr 15; 45(4):599-607. PubMed ID: 8183238
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Fluorescence characteristics of hydrophobic partial agonist probes of the cholecystokinin receptor.
    Harikumar KG, Pinon DI, Miller LJ.
    Biosci Rep; 2006 Apr 15; 26(2):89-100. PubMed ID: 16779661
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.